Health Dec 19 Omicron may sideline two leading drugs against COVID-19 As strained U.S. hospitals brace for a new surge of COVID-19 cases caused by the fast-spreading omicron variant, doctors are warning of yet another challenge: the two standard drugs they’ve used to fight infections are unlikely to work against the…
Health Dec 16 U.S. regulators say abortion pill no longer has to be picked up in person Earlier this year the FDA stopped enforcing the in-person dispending requirement because of the pandemic. Under Thursday's decision the agency will permanently drop the rule.
Politics Dec 14 WATCH: Senate hearing on the nomination of Robert Califf as commissioner of FDA President Joe Biden’s pick to lead the Food and Drug Administration deftly parried questions on crises ranging from the COVID pandemic to the opioid epidemic.
Health Dec 14 Pfizer confirms COVID pill’s results, effectiveness against omicron The company also confirmed Tuesday that the pill delivered on promising early results in reducing COVID-19 hospitalizations and deaths.
Nation Dec 09 FDA expands Pfizer COVID booster, opens extra dose to age 16 The U.S. and many other nations already urge adults to get a booster to pump up their immunity months after initial vaccination.
Health Dec 08 U.S. approves new COVID-19 antibody drug for high-risk patients The drug could benefit cancer patients, organ transplant recipients and people with severe allergies to vaccinations.
Health Nov 30 FDA panel review final hurdle for Merck’s COVID-19 pill U.S. health advisers are reviewing Merck's closely watched COVID-19 pill, which could become the first easy-to-use drug for American patients.
Health Nov 19 WATCH: CDC advisory panel votes approves COVID-19 booster shots for all adults An influential U.S. advisory panel will discuss expanding eligibility for COVID-19 vaccine booster shots to all adults Friday, a move that could make the shots available as early as this weekend.
Health Nov 19 FDA expands COVID boosters to all adults, final hurdle ahead If the Centers for Disease Control and Prevention agrees, tens of millions more Americans could have three doses of protection ahead of the new year. Anyone who got the one-dose Johnson & Johnson vaccine can already get a booster.
Health Nov 16 Pfizer asks U.S. regulators to approve promising COVID pill Pfizer is submitting its experimental pill for COVID-19 for U.S. authorization, setting the stage for a likely launch of the promising therapy in coming weeks.